RPM for respiratory disease
Monitored Therapeutics Inc. (MTI), founded in 2011 and headquartered in Dublin, Ohio, specializes in remote patient monitoring solutions specifically tailored for respiratory diseases. The company's primary focus is on chronic obstructive pulmonary disease (COPD), asthma, lung transplants, and cystic fibrosis. MTI aims to enhance patient care and reduce healthcare costs through its innovative products and technologies.